0.000
0.00 (0.00%)
AIStockmoo Score
| Value 38% | -3.5 |
| Weak profitability. Thin short-term liquidity. Negative cash flow. info | |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Implied Growth info | NA |
| Valuation History info | NA |
| Return on Capital info | NA |
| Holdings' Value info | NA |
| Risk Premium info | NA |
| Market Valuation info | NA |
| Timing 38% | -3.3 |
| Downtrend over the past year. Far below its 52-week high. info | |
| Near its medium-term trend line. info | |
| From our AI technical analysis of the chart. info | NA |
| Technical Setup info | NA |
| Candle Patterns info | NA |
| Sentiment 25% | 0.0 |
| No recent price targets, so based on how targets have been revised. info | |
| Holdings' Sentiment info | NA |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector outperforming the market. | |
| The pillars agree, so the score is strengthened. | |
| Not in score | |
| Earnings per share have mostly fallen. Made a loss in recent years. info | |
| Price Volatility info | NA |
| Trend up on all three terms. info | |
| No clear signal from support and resistance. info | |
| Final Score | -3.35 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Lucy Scientific Discovery Inc. | - | - |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B | Score |
|---|---|---|---|---|---|
| LSDIF | - | - | - | - | -3.3 |
| ZYBT | 72 M | - | - | 2.13 | -1.7 |
| SHPH | 17 M | - | - | 0.200 | -2.4 |
| CANB | 2 M | - | 0.233 | 33.49 | -1.4 |
| CYTHW | - | - | - | - | -3.1 |
| BIOA | - | - | - | 0.680 | -1.9 |
Select this tab to load the latest available analysis.
|
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| % Held by Insiders | 18.03% |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |